Estrella Immunopharma Inc. (ESLA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Estrella Immunopharma Inc...

    NASDAQ: ESLA · Real-Time Price · USD
    1.20
    0.00 (0.00%)
    At close: Sep 29, 2025, 12:16 PM

    Estrella Immunopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
    Cash & Equivalents
    		 916.92K 4.17M 40.8K 4.09M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a 9.67M 45.19M
    Other Long-Term Assets
    		 1.5M n/a n/a n/a
    Receivables
    		 n/a 288.76K n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 723.86K n/a n/a n/a
    Total Current Assets
    		 1.64M 4.45M 52.43K 4.92M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.5M n/a 9.93M 45.19M
    Total Assets
    		 3.14M 4.45M 9.99M 4.92M
    Account Payables
    		 n/a n/a 46.88K 945.59K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 498.6K n/a
    Other Current Liabilities
    		 2.98M 129.72K 8.79M n/a
    Total Current Liabilities
    		 3M 180.7K 1.07M 946.68K
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 1.55M 5.01M
    Total Long-Term Liabilities
    		 n/a n/a 1.84M 5.01M
    Total Liabilities
    		 3M 180.7K 2.92M 5.96M
    Total Debt
    		 n/a n/a 498.6K n/a
    Book Value
    		 143.73K 4.27M 7.07M -1.04M
    Book Value Per Share
    		 0.00 0.12 1.23 -0.18
    Common Stock
    		 3.67K 3.66K 9.33M 18.00
    Retained Earnings
    		 -23.93M -19.5M -2.26M -1.07M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 143.73K 4.27M 7.07M -1.04M
    Total Investments
    		 n/a n/a 9.67M 45.19M

    Add to Watchlist